These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 32927497)

  • 21. Ultrarapid Delayed Rectifier K
    Hilderink S; Devalla HD; Bosch L; Wilders R; Verkerk AO
    Front Cell Dev Biol; 2020; 8():536. PubMed ID: 32850774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biophysical comparison of sodium currents in native cardiac myocytes and human induced pluripotent stem cell-derived cardiomyocytes.
    Goodrow RJ; Desai S; Treat JA; Panama BK; Desai M; Nesterenko VV; Cordeiro JM
    J Pharmacol Toxicol Methods; 2018; 90():19-30. PubMed ID: 29128504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional coculture of sympathetic neurons and cardiomyocytes derived from human-induced pluripotent stem cells.
    Winbo A; Ramanan S; Eugster E; Jovinge S; Skinner JR; Montgomery JM
    Am J Physiol Heart Circ Physiol; 2020 Nov; 319(5):H927-H937. PubMed ID: 32822546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atrial-like cardiomyocytes from human pluripotent stem cells are a robust preclinical model for assessing atrial-selective pharmacology.
    Devalla HD; Schwach V; Ford JW; Milnes JT; El-Haou S; Jackson C; Gkatzis K; Elliott DA; Chuva de Sousa Lopes SM; Mummery CL; Verkerk AO; Passier R
    EMBO Mol Med; 2015 Apr; 7(4):394-410. PubMed ID: 25700171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human induced pluripotent stem cell-derived versus adult cardiomyocytes: an in silico electrophysiological study on effects of ionic current block.
    Paci M; Hyttinen J; Rodriguez B; Severi S
    Br J Pharmacol; 2015 Nov; 172(21):5147-60. PubMed ID: 26276951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of KCNJ2 in induced pluripotent stem cell-derived cardiomyocytes for the assessment of QT-prolonging drugs.
    Li M; Kanda Y; Ashihara T; Sasano T; Nakai Y; Kodama M; Hayashi E; Sekino Y; Furukawa T; Kurokawa J
    J Pharmacol Sci; 2017 Jun; 134(2):75-85. PubMed ID: 28615142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibiting microRNA-155 attenuates atrial fibrillation by targeting CACNA1C.
    Wang J; Ye Q; Bai S; Chen P; Zhao Y; Ma X; Bai C; Liu Y; Xin M; Zeng C; Liu Q; Zhao C; Yao Y; Ma Y
    J Mol Cell Cardiol; 2021 Jun; 155():58-65. PubMed ID: 33636223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human Atrial Cardiac Microtissues for Chamber-Specific Arrhythmic Risk Assessment.
    Soepriatna AH; Kim TY; Daley MC; Song E; Choi BR; Coulombe KLK
    Cell Mol Bioeng; 2021 Oct; 14(5):441-457. PubMed ID: 34777603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening drug-induced arrhythmia [corrected] using human induced pluripotent stem cell-derived cardiomyocytes and low-impedance microelectrode arrays.
    Navarrete EG; Liang P; Lan F; Sanchez-Freire V; Simmons C; Gong T; Sharma A; Burridge PW; Patlolla B; Lee AS; Wu H; Beygui RE; Wu SM; Robbins RC; Bers DM; Wu JC
    Circulation; 2013 Sep; 128(11 Suppl 1):S3-13. PubMed ID: 24030418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biophysical properties of Na
    Chapotte-Baldacci CA; Pierre M; Djemai M; Pouliot V; Chahine M
    Sci Rep; 2023 Nov; 13(1):20685. PubMed ID: 38001331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of basal and norepinephrine-induced cAMP and I
    Iqbal Z; Ismaili D; Dolce B; Petersen J; Reichenspurner H; Hansen A; Kirchhof P; Eschenhagen T; Nikolaev VO; Molina CE; Christ T
    Cell Signal; 2021 Jun; 82():109970. PubMed ID: 33677066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Electrophysiological identification of human induced pluripotent stem cell-derived cardiomyocytes].
    Zhang HY; Zhang TT; Machuki JO; Wu LJ; Sun H
    Sheng Li Xue Bao; 2018 Jun; 70(3):281-286. PubMed ID: 29926069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human Induced Pluripotent Stem Cell-Derived Cardiac Cell Sheets Expressing Genetically Encoded Voltage Indicator for Pharmacological and Arrhythmia Studies.
    Shaheen N; Shiti A; Huber I; Shinnawi R; Arbel G; Gepstein A; Setter N; Goldfracht I; Gruber A; Chorna SV; Gepstein L
    Stem Cell Reports; 2018 Jun; 10(6):1879-1894. PubMed ID: 29754959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intermittent Optogenetic Tachypacing of Atrial Engineered Heart Tissue Induces Only Limited Electrical Remodelling.
    Lemoine MD; Lemme M; Ulmer BM; Braren I; Krasemann S; Hansen A; Kirchhof P; Meyer C; Eschenhagen T; Christ T
    J Cardiovasc Pharmacol; 2020 Dec; 77(3):291-299. PubMed ID: 33278190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. hiPSC-CM Monolayer Maturation State Determines Drug Responsiveness in High Throughput Pro-Arrhythmia Screen.
    da Rocha AM; Campbell K; Mironov S; Jiang J; Mundada L; Guerrero-Serna G; Jalife J; Herron TJ
    Sci Rep; 2017 Oct; 7(1):13834. PubMed ID: 29061979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subtype-specific differentiation of cardiac pacemaker cell clusters from human induced pluripotent stem cells.
    Schweizer PA; Darche FF; Ullrich ND; Geschwill P; Greber B; Rivinius R; Seyler C; Müller-Decker K; Draguhn A; Utikal J; Koenen M; Katus HA; Thomas D
    Stem Cell Res Ther; 2017 Oct; 8(1):229. PubMed ID: 29037217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optical Investigation of Action Potential and Calcium Handling Maturation of hiPSC-Cardiomyocytes on Biomimetic Substrates.
    Pioner JM; Santini L; Palandri C; Martella D; Lupi F; Langione M; Querceto S; Grandinetti B; Balducci V; Benzoni P; Landi S; Barbuti A; Ferrarese Lupi F; Boarino L; Sartiani L; Tesi C; Mack DL; Regnier M; Cerbai E; Parmeggiani C; Poggesi C; Ferrantini C; Coppini R
    Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31382622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioengineering approaches to mature induced pluripotent stem cell-derived atrial cardiomyocytes to model atrial fibrillation.
    Ly OT; Brown GE; Han YD; Darbar D; Khetani SR
    Exp Biol Med (Maywood); 2021 Aug; 246(16):1816-1828. PubMed ID: 33899540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blinded Contractility Analysis in hiPSC-Cardiomyocytes in Engineered Heart Tissue Format: Comparison With Human Atrial Trabeculae.
    Mannhardt I; Eder A; Dumotier B; Prondzynski M; Krämer E; Traebert M; Söhren KD; Flenner F; Stathopoulou K; Lemoine MD; Carrier L; Christ T; Eschenhagen T; Hansen A
    Toxicol Sci; 2017 Jul; 158(1):164-175. PubMed ID: 28453742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte (hiPSC-CM) Multielectrode Array Assay for Preclinical Cardiac Electrophysiology Safety Screening.
    Harris K
    Curr Protoc Pharmacol; 2015 Dec; 71():11.18.1-11.18.15. PubMed ID: 26646193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.